14-92071010-CCTGCTGCTGCTG-CCTGCTGCTGCTGCTGCTGCTGCTGCTGCTGCTGCTGCTGCTGCTGCTGCTG

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP3BP6_ModerateBA1

The NM_004993.6(ATXN3):​c.915_916insCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG​(p.Gln305_Gly306insGlnGlnGlnGlnGlnGlnGlnGlnGlnGlnGlnGlnGln) variant causes a conservative inframe insertion change involving the alteration of a non-conserved nucleotide. It is difficult to determine the true allele frequency of this variant because it is of type INS_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.069 ( 524 hom., cov: 20)
Exomes 𝑓: 0.025 ( 221 hom. )
Failed GnomAD Quality Control

Consequence

ATXN3
NM_004993.6 conservative_inframe_insertion

Scores

Not classified

Clinical Significance

Benign criteria provided, single submitter B:2

Conservation

PhyloP100: -0.168

Publications

1 publications found
Variant links:
Genes affected
ATXN3 (HGNC:7106): (ataxin 3) Machado-Joseph disease, also known as spinocerebellar ataxia-3, is an autosomal dominant neurologic disorder. The protein encoded by this gene contains (CAG)n repeats in the coding region, and the expansion of these repeats from the normal 12-44 to 52-86 is one cause of Machado-Joseph disease. There is a negative correlation between the age of onset and CAG repeat numbers. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jul 2016]
ATXN3 Gene-Disease associations (from GenCC):
  • Machado-Joseph disease
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae)
  • Machado-Joseph disease type 1
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Machado-Joseph disease type 2
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Machado-Joseph disease type 3
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_004993.6
BP6
Variant 14-92071010-C-CCTGCTGCTGCTGCTGCTGCTGCTGCTGCTGCTGCTGCTG is Benign according to our data. Variant chr14-92071010-C-CCTGCTGCTGCTGCTGCTGCTGCTGCTGCTGCTGCTGCTG is described in ClinVar as Benign. ClinVar VariationId is 1050021.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0973 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATXN3NM_004993.6 linkc.915_916insCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG p.Gln305_Gly306insGlnGlnGlnGlnGlnGlnGlnGlnGlnGlnGlnGlnGln conservative_inframe_insertion Exon 10 of 11 ENST00000644486.2 NP_004984.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATXN3ENST00000644486.2 linkc.915_916insCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG p.Gln305_Gly306insGlnGlnGlnGlnGlnGlnGlnGlnGlnGlnGlnGlnGln conservative_inframe_insertion Exon 10 of 11 NM_004993.6 ENSP00000496695.1

Frequencies

GnomAD3 genomes
AF:
0.0695
AC:
9883
AN:
142238
Hom.:
524
Cov.:
20
show subpopulations
Gnomad AFR
AF:
0.0488
Gnomad AMI
AF:
0.107
Gnomad AMR
AF:
0.102
Gnomad ASJ
AF:
0.0660
Gnomad EAS
AF:
0.00409
Gnomad SAS
AF:
0.0352
Gnomad FIN
AF:
0.0723
Gnomad MID
AF:
0.0230
Gnomad NFE
AF:
0.0801
Gnomad OTH
AF:
0.0680
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0249
AC:
32736
AN:
1312834
Hom.:
221
Cov.:
92
AF XY:
0.0263
AC XY:
17266
AN XY:
656116
show subpopulations
African (AFR)
AF:
0.0207
AC:
569
AN:
27524
American (AMR)
AF:
0.0433
AC:
1751
AN:
40482
Ashkenazi Jewish (ASJ)
AF:
0.0335
AC:
817
AN:
24384
East Asian (EAS)
AF:
0.00192
AC:
72
AN:
37442
South Asian (SAS)
AF:
0.0223
AC:
1773
AN:
79462
European-Finnish (FIN)
AF:
0.0560
AC:
2734
AN:
48850
Middle Eastern (MID)
AF:
0.0288
AC:
148
AN:
5136
European-Non Finnish (NFE)
AF:
0.0230
AC:
22900
AN:
994524
Other (OTH)
AF:
0.0358
AC:
1972
AN:
55030
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.410
Heterozygous variant carriers
0
1781
3562
5342
7123
8904
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
116
232
348
464
580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0695
AC:
9888
AN:
142348
Hom.:
524
Cov.:
20
AF XY:
0.0696
AC XY:
4814
AN XY:
69142
show subpopulations
African (AFR)
AF:
0.0488
AC:
1770
AN:
36280
American (AMR)
AF:
0.102
AC:
1462
AN:
14384
Ashkenazi Jewish (ASJ)
AF:
0.0660
AC:
225
AN:
3408
East Asian (EAS)
AF:
0.00410
AC:
19
AN:
4634
South Asian (SAS)
AF:
0.0353
AC:
152
AN:
4310
European-Finnish (FIN)
AF:
0.0723
AC:
713
AN:
9862
Middle Eastern (MID)
AF:
0.0177
AC:
5
AN:
282
European-Non Finnish (NFE)
AF:
0.0801
AC:
5315
AN:
66346
Other (OTH)
AF:
0.0678
AC:
133
AN:
1962
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
368
736
1103
1471
1839
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
110
220
330
440
550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0280
Hom.:
345

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Feb 16, 2025
Laboratory of Genetics, Children's Clinical University Hospital Latvia
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

The ATXN3 p.Ala22_Gly23ins13 variant was identified in dbSNP (ID: rs763541221), ClinVar, Cosmic and LOVD 3.0. The variant was not identified in the following control databases: the 1000 Genomes Project, the NHLBI GO Exome Sequencing Project, the Exome Aggregation Consortium (August 8th 2016), or the Genome Aggregation Database (Feb 27, 2017). This variant is an in-frame insertion resulting in the inclusion of 13 CAG repeats. The (CAG)n repeat within the ATXN3 gene was found to cause Machado-Joseph disease at 73-78 repeats while 14-40 repeats was considered the normal range (Limprasert_1996_PMID: 8824876). More recent studies have suggested 52 to 86 repeats as pathogenic (GeneReviews). This CAG repeat expansion would fall within the normal range and this variant is predicted to be a polymorphism by MutationTaster. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.17
Mutation Taster
=80/20
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs193922928; hg19: chr14-92537354; COSMIC: COSV61495655; COSMIC: COSV61495655; API